Search - tctmd.com

Displaying 261 - 280 of 805

Sort: Relevancy | Date

News Daily News

Mental Health a Concern for Many Cardiologists: ACC Survey

L.A. McKeown

January 06, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Gay Men, Bisexual Women Face Unique Hypertension Risks

Caitlin E. Cox

January 03, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2022

Caitlin E. Cox

January 02, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

L.A. McKeown

December 29, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

Todd Neale

December 21, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Features

Bullying in Cardiology: Has More Diversity Led to Backlash?

Caitlin E. Cox

December 14, 2022

News Daily News

Age-Related Macular Degeneration Linked to Severe Vascular Disease

Caitlin E. Cox

November 18, 2022

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

L.A. McKeown

November 09, 2022

News Conference News AHA 2022

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Caitlin E. Cox

November 08, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

Todd Neale

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

Advertisement

Mental Health a Concern for Many Cardiologists: ACC Survey

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Gay Men, Bisexual Women Face Unique Hypertension Risks

Top Policy and Practice News for Cardiologists in 2022

The Biggest News of 2022: TCTMD’s Top 10

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

December 2022 News Roundup

Top General Cardiology and Prevention News of 2022

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Bullying in Cardiology: Has More Diversity Led to Backlash?

Age-Related Macular Degeneration Linked to Severe Vascular Disease

China Rural Intervention Still Reaping BP Control Wins at 3 Years

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content